Repare Therapeutics Net Income From Continuing Ops Over Time
| RPTX Stock | USD 3.28 0.04 1.20% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Repare Therapeutics Performance and Repare Therapeutics Correlation. Repare |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repare Therapeutics. If investors know Repare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repare Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.99) | Revenue Per Share 1.572 | Quarterly Revenue Growth (0.96) | Return On Assets (0.23) | Return On Equity (0.41) |
The market value of Repare Therapeutics is measured differently than its book value, which is the value of Repare that is recorded on the company's balance sheet. Investors also form their own opinion of Repare Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Repare Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repare Therapeutics' market value can be influenced by many factors that don't directly affect Repare Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repare Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Repare Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repare Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income From Continuing Ops Analysis
Compare Repare Therapeutics and related stocks such as Accolade, Nurix Therapeutics, and 908 Devices Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACCD | (61.3 M) | (61.3 M) | (61.3 M) | (61.3 M) | (61.3 M) | (61.3 M) | (61.3 M) | (61.3 M) | (56.5 M) | (50.7 M) | (50.7 M) | (123.1 M) | (459.6 M) | (99.8 M) | (104.8 M) |
| NRIX | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (21.7 M) | (43.2 M) | (117.2 M) | (180.4 M) | (143.9 M) | (129.6 M) | (136 M) |
| MASS | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (13.4 M) | (12.8 M) | (22.2 M) | (33.6 M) | (38.8 M) | (36.8 M) |
| RLAY | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (75.3 M) | (52.4 M) | (363.9 M) | (290.5 M) | (342 M) | (324.9 M) |
Repare Therapeutics and related stocks such as Accolade, Nurix Therapeutics, and 908 Devices Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Repare Therapeutics | RPTX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Quebec; Canada |
| Exchange | NASDAQ Exchange |
USD 3.28
Additional Tools for Repare Stock Analysis
When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.